Circulating adiponectin in patients with nonalcoholic fatty liver disease‐related liver fibrosis: A systematic review and a meta‐analysis

Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies

(2021) Julie Steen Pedersen et al.   Journal of Clinical Medicine

Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD

(2021) Vanda Marques et al.   Frontiers in Medicine

Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis

(2020) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

From NAFLD to MAFLD: Implications of a premature change in terminology

(2020) Zobair M Younossi et al.   HEPATOLOGY

Commentary: nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name

(2020) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease

(2020) Evangelia Makri et al.   ARCHIVES OF MEDICAL RESEARCH

The impact of bariatric surgery on nonalcoholic fatty liver disease as measured using non-invasive tests

(2020) Carmit Netanel et al.   AMERICAN JOURNAL OF SURGERY

Non-Invasive Assessment of Liver Disease in Patients with NAFLD

(2019) Laurent Castera et al.   GASTROENTEROLOGY

Hepatic iron is the major determinant of serum ferritin in NAFLD patients

(2017) John D. Ryan et al.   LIVER INTERNATIONAL

Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus

(2016) Kenneth Cusi et al.   ANNALS OF INTERNAL MEDICINE

Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease

(2016) Shikha S. Sundaram et al.   JOURNAL OF HEPATOLOGY

Nonalcoholic fatty future disease

(2016) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Adipokines in nonalcoholic fatty liver disease

(2016) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review

(2016) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease

(2016) Raika Jamali et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity

(2015) Kavya Anjani et al.   JOURNAL OF HEPATOLOGY

Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease

(2015) Cemal Nuri Ercin et al.   Metabolic Syndrome and Related Disorders

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease

(2013) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls

(2012) Luca Valenti et al.   BMC GASTROENTEROLOGY

Nonalcoholic Fatty Liver Disease

(2012) Stergios A. Polyzos et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Adiponectin in non-alcoholic fatty liver disease treatment: therapeutic perspectives and unresolved dilemmas

(2011) S. A. Polyzos et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

372 USEFULNESS OF SERUM HIGH-SENSITIVITY CRP MEASUREMENT IN DIFFERENTIATING NON-ALCOHOLIC STEATOHEPATITIS AND SIMPLE STEATOSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

(2010) S. Siramolpiwat et al.   JOURNAL OF HEPATOLOGY

Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis

(2010) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis

(2010) Zobair M. Younossi et al.   OBESITY SURGERY

The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease

(2009) Stergios A. Polyzos et al.   DIABETES OBESITY & METABOLISM

Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

(2008) Vlad Ratziu et al.   GASTROENTEROLOGY

Serum adipokine levels in chronic liver diseases: Association of resistin levels with fibrosis severity

(2008) Emmanuel Tsochatzis et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY